Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB26FDQDY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,963
Award facts
- Contract value 100% obligated
- $13,963.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,963.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for PRIVIGEN 10% Vial 200ML, an immunoglobulin product used for treating immunodeficiency disorders and certain autoimmune conditions. The award was issued on October 28, 2025, with completion targeted for November 19, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. This delivery order represents a discrete procurement action issued against DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Department of Defense pharmaceutical supply initiative designed to ensure reliable access to medications and medical supplies across military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program with a $499,999,999 ceiling value and a performance period extending through December 31, 2036, positioning the company as a critical regional pharmaceutical supplier for DoD medical operations. The company's established track record supplying diverse pharmaceutical products—ranging from specialty biologics and oncology treatments to routine medications and vaccines—demonstrates its capability to fulfill the specialized requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FDQDY?
SPE2DB26FDQDY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FDQDY worth?
The government has obligated $13,963 on SPE2DB26FDQDY.
Is contract SPE2DB26FDQDY an order under another contract?
Yes. SPE2DB26FDQDY is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB26FDQDY competed?
The extent of competition for SPE2DB26FDQDY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award